VIVE - Viveve MedicalAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $3.18 | Open | $3.26 |
| Volume | 2.22M | Market Cap | 68.64M |
| Yield | Last Dividend |
| The Daily Biotech Pulse: Bausch Health I... | 01/13/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) Abb... | |
| Viveve Regains Compliance with NASDAQ Co... | 12/17/20 |
| ENGLEWOOD, CO / ACCESSWIRE / December 17, 2020 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women???s intimate health... | |
| The Daily Biotech Pulse: AstraZeneca Pau... | 09/09/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase... | |
| The Daily Biotech Pulse: Altimmune Repor... | 08/25/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Abbott Laboratories (NYSE: ABT ) Cancer Genetics Inc (NASDAQ: CGIX ) (announced a dea... | |
| Viveve Medical : Reports Second Quarter ... | 08/13/20 |
| Viveve Reports Second Quarter 2020 Financial Results and Provides Corporate Update Download as PDFAugust 13, 2020 Advanced critical SUI feasibility??? | |
| Why Viveve Medical's Stock Is Trading Lo... | 04/09/20 |
| Viveve Medical (NASDAQ: VIVE ) shares are trading lower on Thursday, after the company announced that the vive pivotal VIVEVE 2 study did not meet its... | |
| Viveve Medical : Announces Closing of $1... | 11/26/19 |
| ENGLEWOOD, CO / ACCESSWIRE / November 26, 2019 / Viveve Medical, Inc. , a medical technology company focused on women's intimate health, today announc... | |
| The Daily Biotech Pulse: Merck Goes Shop... | 11/13/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ... | |
| The Daily Biotech Pulse: Arbutus Halts H... | 10/04/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 3) Ap... | |
| The Daily Biotech Pulse: Acceleron Shelv... | 09/17/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 16)... | |
| Viveve Medical, Inc. (VIVE) CEO Scott Du... | 05/13/19 |
| Viveve Medical, Inc. (NASDAQ:VIVE) Q1 2019 Earnings Conference Call May 9, 2019 17:00 ET Company Participants Jeannie Swindle - Senior Director of Cor... | |
| Viveve Medical beats by $0.07, misses on... | 05/09/19 |
| No summary available. | |
| Research From The 2019 ECCMID Conference... | 05/09/19 |
| No summary available. | |
| 33 Stocks Moving In Friday???s Pre-Marke... | 04/12/19 |
| Gainers Viveve Medical Inc (NASDAQ: VIVE) shares rose 34.7 percent to $0.78 in pre-market trading following news of CE Mark clearance for its next-gen... | |
| Conformis Is A Failed Market Experiment,... | 04/11/19 |
| No summary available. | |
| The Daily Biotech Pulse: KaryoPharm's Se... | 03/15/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 14)... | |
| Viveve Medical, Inc. (VIVE) CEO Scott Du... | 03/14/19 |
| No summary available. | |
| Viveve Medical misses by $0.03, beats on... | 03/14/19 |
| No summary available. | |
| Viveve Medical (VIVE) Investor Presentat... | 03/11/19 |
| No summary available. | |
| Viveve completes enrollment in VIVEVE II... | 03/11/19 |
| No summary available. | |
| Why Hospitals Are Not Buying The T2 Bios... | 03/05/19 |
| No summary available. | |
| Helius Medical: A Failed Clinical Trial,... | 01/29/19 |
| No summary available. | |
| Viveve sees FY 2018 revenue as high as $... | 01/16/19 |
| No summary available. | |
| Viveve sees FY 2018 revenue as high as $... | 01/16/19 |
| No summary available. | |
| Date | 2020-11-12 (AMC) | Est. (EPS/Rev.) | ($0.53)/ 1M |
| Actual (EPS/Rev.) | $-0.26/ $1.52 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 66.00 % | Follow |
| Mojo Day Trading | ProTrader Mike | 46.00 % | Subscribe |
| R R Investments | Roland Van Rij | 38.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
